Burçin Şimşek

39 papers receiving 1.1k citations

Burçin Şimşek's Hit Papers

Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial 2022 · 192 citations
1920+1+2Years since publication50100150

Peers

Burçin Şimşek
Comparison fields: 5 of 96
  • Pulmonary and Respiratory Medicine 563
  • Oncology 391
  • Cancer Research 156
  • Algebra and Number Theory 51
  • Discrete Mathematics and Combinatorics 34
Replace Gebra Cuyún Carter with:
Gebra Cuyún Carter United States
M.H. Skolnick United States
Xiaoyun Li United States
Tatjana Kolevska United States
Marco Fornili Italy
L M Parker United States
Javad Shahidi United States
Håkon Wæhre Norway
Alastair Lamb United Kingdom
Georgeta Fried Israel
Burçin Şimşek relative to Gebra Cuyún Carter United States Gebra Cuyún Carter's profile →
Citations per field
00.5×2.6×
Gebra Cuyún Carter · 1×
Citations per year

Countries citing papers authored by Burçin Şimşek

Since Specialization
Citations

This map shows the geographic impact of Burçin Şimşek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burçin Şimşek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burçin Şimşek more than expected).

Fields of papers citing papers by Burçin Şimşek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burçin Şimşek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burçin Şimşek. The network helps show where Burçin Şimşek may publish in the future.

Co-authors

The 25 scholars most cited alongside Burçin Şimşek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Burçin Şimşek Line = papers co-authored together Burçin Şimşek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020273
2
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
Hit paper breakdown →
2022192
3 202086
4 201785
5 202262
6 201762
7 202153
8 202049
9 202228
10 201827
11 201920
12 202118
13 202116
14 202216
15 202013
16 202213
17 201713
18 202112
19 201712
20 201910

About Burçin Şimşek

Burçin Şimşek is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, Applied Mathematics and Algebra and Number Theory, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Cancer Immunotherapy and Biomarkers (9 papers), Economic and Financial Impacts of Cancer (7 papers), Advanced Mathematical Identities (5 papers), Mathematical functions and polynomials (5 papers), Reproductive Health and Technologies (5 papers), Cancer Genomics and Diagnostics (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (563 citations), Oncology (391 citations), Cancer Research (156 citations), Algebra and Number Theory (51 citations) and Discrete Mathematics and Combinatorics (34 citations). Burçin Şimşek has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Robert J. Motzer, Toni K. Choueiri, Andrea B. Apolo, Cristina Suárez, Joshua Zhang, Bernard Escudier, Thomas Powles, Amishi Y. Shah, Mauricio Burotto and María T. Bourlon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Fertility and Sterility, The Lancet Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact